Pretreatment of kidney allografts with anti-CD5 immunotoxin: a new chance for high responder recipients.
Alexeev
L P
LP
Institute of Immunology, Moscow, Russia.
Toptygin AYu
Korenkova
E V
EV
Yan G Moisiuk
Y
Y
Muromtseva
I B
IB
Tonevitsky
A G
AG
Dolbin
A G
AG
Sechkin
A V
AV
Shumakov
V I
VI
Vasilov
R G
RG
Khaitov
R M
RM
D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000276:immunology; D001323:Autoantibodies / Q000097:blood; D018956:CD5 Antigens / Q000276:immunology*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D007668:Kidney / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008212:Lymphocyte Depletion / Q000379:methods*; D012276:Ricin / Q000627:therapeutic use*; D016019:Survival Analysis; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D001323:Autoantibodies; D018956:CD5 Antigens; D000922:Immunotoxins; D012276:Ricin